FDA NDC Directory · JSON-LD · Markdown

WEGOVY

NDC 0169-4501 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic namesemaglutide
Labeler / ManufacturerNovo Nordisk
Marketing categoryNew Drug Application (innovator) · App NDA215256
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsSEMAGLUTIDE (1 mg/.5mL)
Marketing started20210605
Package count1

External sources

Source: openFDA. Public-domain (CC0).